1. Home
  2. TNGX vs JBSS Comparison

TNGX vs JBSS Comparison

Compare TNGX & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • JBSS
  • Stock Information
  • Founded
  • TNGX 2014
  • JBSS 1959
  • Country
  • TNGX United States
  • JBSS United States
  • Employees
  • TNGX 140
  • JBSS N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • JBSS Specialty Foods
  • Sector
  • TNGX Health Care
  • JBSS Consumer Staples
  • Exchange
  • TNGX Nasdaq
  • JBSS Nasdaq
  • Market Cap
  • TNGX 747.9M
  • JBSS 1.1B
  • IPO Year
  • TNGX N/A
  • JBSS 1991
  • Fundamental
  • Price
  • TNGX $6.98
  • JBSS $93.38
  • Analyst Decision
  • TNGX Strong Buy
  • JBSS
  • Analyst Count
  • TNGX 8
  • JBSS 0
  • Target Price
  • TNGX $15.14
  • JBSS N/A
  • AVG Volume (30 Days)
  • TNGX 1.3M
  • JBSS 99.0K
  • Earning Date
  • TNGX 11-06-2024
  • JBSS 10-29-2024
  • Dividend Yield
  • TNGX N/A
  • JBSS 2.40%
  • EPS Growth
  • TNGX N/A
  • JBSS N/A
  • EPS
  • TNGX N/A
  • JBSS 5.15
  • Revenue
  • TNGX $42,509,000.00
  • JBSS $1,066,782,999.00
  • Revenue This Year
  • TNGX $18.15
  • JBSS N/A
  • Revenue Next Year
  • TNGX N/A
  • JBSS N/A
  • P/E Ratio
  • TNGX N/A
  • JBSS $18.03
  • Revenue Growth
  • TNGX 26.16
  • JBSS 6.71
  • 52 Week Low
  • TNGX $5.15
  • JBSS $89.73
  • 52 Week High
  • TNGX $13.01
  • JBSS $108.96
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 33.20
  • JBSS 45.09
  • Support Level
  • TNGX $6.72
  • JBSS $92.20
  • Resistance Level
  • TNGX $7.78
  • JBSS $97.35
  • Average True Range (ATR)
  • TNGX 0.56
  • JBSS 1.81
  • MACD
  • TNGX -0.11
  • JBSS 0.09
  • Stochastic Oscillator
  • TNGX 8.48
  • JBSS 28.98

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and under the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also market and distribute, and in the majority of cases, manufacture or process, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

Share on Social Networks: